Literature DB >> 4155933

Hydralazine and beta-adrenergic blockade in the treatment of hypertension.

L Siitonen, J Jänne, O Keyriläinen, P Koskinen, O Leskinen, T Pitkäjärvi, M Reinikainen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4155933

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN： 0003-4762


× No keyword cloud information.
  3 in total

Review 1.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

2.  Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.

Authors:  E van der Veur; B S ten Berge; A J Donker; J F May; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine.

Authors:  T Pitkäjärvi; P Ala-Laurila; R Ruosteenoja; P Torsti; S E Masar
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.